Transplantation of umbilical cord-derived mesenchymal stem cells into the striata of R6/2 mice: Behavioral and neuropathological analysis

Stem Cell Research and Therapy

Volumn 4, Issue 5, 2013, Pages

  Fink, Kyle D ^a,b,c   Rossignol, Julien ^a,d   Crane, Andrew T ^a   Davis, Kendra K ^a   Bombard, Matthew C ^a   Bavar, Angela M ^a   Clerc, Steven ^a   Lowrance, Steven A ^a   Song, Cheng ^a   Lescaudron, Laurent ^c,e   Dunbar, Gary L ^a,f  

^a CENTRAL MICHIGAN UNIVERSITY   (United States)

^b UNIVERSITÉ DE NANTES   (France)

^c INSERM   (France)

^d Central Michigan University College of Medicine   (United States)

^e Universite de Nantes   (France)

^f Field Neurosciences Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL BEHAVIOR; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ISOLATION; CELL SURVIVAL; CONTROLLED STUDY; CORD BLOOD STEM CELL TRANSPLANTATION; FEMALE; GESTATION PERIOD; HUNTINGTON CHOREA; IMMUNE RESPONSE; LIMB MOVEMENT; MALE; MAZE TEST; MESENCHYMAL STEM CELL; MESENCHYMAL STEM CELL TRANSPLANTATION; MOUSE; NEUROPATHOLOGY; NEWBORN; NONHUMAN; PRIORITY JOURNAL; ROTAROD TEST; SPATIAL MEMORY; TASK PERFORMANCE; TISSUE SECTION; TRANSGENIC MOUSE; TREATMENT OUTCOME;

MUS; RODENTIA;

ANIMALS; BEHAVIOR, ANIMAL; BRAIN; BRAIN-DERIVED NEUROTROPHIC FACTOR; DISEASE MODELS, ANIMAL; FEMALE; HUNTINGTON DISEASE; MALE; MEMORY; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MOTOR ACTIVITY; UMBILICAL CORD;

EID: 84886068413     PISSN: None     EISSN: 17576512     Source Type: Journal    
DOI: 10.1186/scrt341     Document Type: Article

References (34)

1. Excitotoxic neuronal death and the pathogenesis of Huntington's disease. Estrada Sánchez AM, Mejía-Toiber J, Massieu L, Arch Med Res 2008 39 265 276 10.1016/j.arcmed.2007.11.011 18279698 (Pubitemid 351221151)
2. Intrabody gene therapy ameliorates motor, cognitive, and neuropathological symptoms in multiple mouse models of Huntington's disease. Southwell AL, Ko J, Patterson PH, J Neurosci 2009 29 13589 13602 10.1523/JNEUROSCI.4286-09.2009 19864571
3. Abnormal synaptic plasticity and impaired spatial cognition in mice transgenic for exon 1 of the human Huntington's disease mutation. Murphy KP, Carter RJ, Lione LA, Mangiarini L, Mahal A, Bates GP, Dunnett SB, Morton AJ, J Neurosci 2000 20 5115 5123 10864968 (Pubitemid 30421714)
4. Beneficial effects of rolipram in the R6/2 mouse model of Huntington's disease. DeMarch Z, Giampà C, Patassini S, Bernardi G, Fusco FR, Neurobiol Dis 2008 30 375 387 10.1016/j.nbd.2008.02.010 18424161
5. Human umbilical cord blood cells ameliorate Huntington's disease in transgenic mice. Ende N, Chen R, J Med 2001 32 231 240 11563820 (Pubitemid 32899515)
6. Slowed progression in models of Huntington disease by adipose stem cell transplantation. Lee ST, Chu K, Jung KH, Im WS, Park JE, Lim HC, Won CH, Shin SH, Lee SK, Kim M, Roh JK, Ann Neurol 2009 66 671 681 10.1002/ana.21788 19938161
7. Mesenchymal stem cell transplantation and DMEM administration in a 3NP rat model of Huntington's disease: morphological and behavioral outcomes. Rossignol J, Boyer C, Lévèque X, Fink KD, Thinard R, Blanchard F, Dunbar GL, Lescaudron L, Behav Brain Res 2011 217 369 378 10.1016/j.bbr.2010.11. 006 21070819
8. Behavioral and neurolopathological sparing in the R6/2 mouse model of Huntington's disease following transplantation of bone-marrow-derived mesenchymal stem cells is dependent on passage number. Rossignol J, Fink KD, Crane AT, Davis KK, Bombard MC, Clerc S, Bavar AM, Lowrance SA, Song C, Witte SJ, Lescaudron L, Dunbar GL, Stem Cells Dev In Review
9. A comparison of pluripotency and differentiation status of four mesenchymal adult stem cells. Adegani FJ, Langroudi L, Arefian E, Shafiee A, Dinarvand P, Soleimani M, Mol Biol Rep 2013 40 3693 3703 10.1007/s11033-012- 2445-7 23275202
10. Stem cells in the umbilical cord. Weiss ML, Troyer DL, Stem Cell Rev 2006 2 155 162 10.1007/s12015-006-0022-y 17237554 (Pubitemid 46137576)
11. Biology of stem cells in human umbilical cord stroma: in situ and in vitro surveys. Karahuseyinoglu S, Cinar O, Kilic E, Kara F, Akay GG, Demiralp DO, Tukun A, Uckan D, Can A, Stem Cells 2007 25 319 331 10.1634/stemcells.2006- 0286 17053211 (Pubitemid 46232786)
12. Characterization of mesenchymal stromal cells derived from full-term umbilical cord blood. Manca MF, Zwart I, Beo J, Palasingham R, Jen LS, Navarrete R, Girdlestone J, Navarrete CV, Cytotherapy 2008 10 54 68 10.1080/ 14653240701732763 18202975
13. Untying the Gordian knot: policies, practices, and ethical issues related to banking of umbilical cord blood. Kurtzberg J, Lyerly AD, Sugarman J, J Clin Invest 2005 115 2592 2597 10.1172/JCI26690 16200191 (Pubitemid 41434381)
14. Hematopoietic engraftment and survival in adult recipients of umbilical-cord blood from unrelated donors. Laughlin MJ, Barker J, Bambach B, Koc ON, Rizzieri DA, Wagner JE, Gerson SL, Lazarus HM, Cairo M, Stevens CE, Rubinstein P, Kurtzberg J, N Engl J Med 2001 344 1815 1822 10.1056/ NEJM200106143442402 11407342 (Pubitemid 32538694)
15. Expression of early transcription factors Oct-4, Sox-2 and Nanog by porcine umbilical cord (PUC) matrix cells. Carlin R, Davis D, Weiss M, Schultz B, Troyer D, Reprod Biol Endocrinol 2006 4 8 10.1186/1477-7827-4-8 16460563 (Pubitemid 43264329)
16. The therapeutic potential, challenges and future clinical directions of stem cells from the Wharton's jelly of the human umbilical cord. Bongso A, Fong CY, Stem Cell Rev 2013 9 226 240 10.1007/s12015-012-9418-z 23233233
17. Comparative growth behaviour and characterization of stem cells from human Wharton's jelly. Fong CY, Richards M, Manasi N, Biswas A, Bongso A, Reprod Biomed Online 2007 15 708 718 10.1016/S1472-6483(10)60539-1 18062871 (Pubitemid 350285987)
18. Conversion of human umbilical cord mesenchymal stem cells in Wharton's jelly to dopaminergic neurons in vitro: potential therapeutic application for Parkinsonism. Fu YS, Cheng YC, Lin MY, Cheng H, Chu PM, Chou SC, Shih YH, Ko MH, Sung MS, Stem Cells 2006 24 115 124 10.1634/stemcells.2005-0053 16099997
19. Transformation of human umbilical mesenchymal cells into neurons in vitro. Fu YS, Shih YT, Cheng YC, Min MY, J Biomed Sci 2004 11 652 660 10.1007/BF02256131 15316141
20. Matrix cells from Wharton's jelly form neurons and glia. Mitchell KE, Weiss ML, Mitchell BM, Martin P, Davis D, Morales L, Helwig B, Beerenstrauch M, Abou-Easa K, Hildreth T, Troyer D, Medicetty S, Stem Cells 2003 21 50 60 10.1634/stemcells.21-1-50 12529551 (Pubitemid 36120365)
21. Mesenchymal stem cells in the Wharton's jelly of the human umbilical cord. Wang HS, Hung SC, Peng ST, Huang CC, Wei HM, Guo YJ, Fu YS, Lai MC, Chen CC, Stem Cells 2004 22 1330 1337 10.1634/stemcells.2004-0013 15579650 (Pubitemid 39636408)
22. Transplantation of pig stem cells into rat brain: proliferation during the first 8 weeks. Medicetty S, Bledsoe AR, Fahrenholtz CB, Troyer D, Weiss ML, Exp Neurol 2004 190 32 41 10.1016/j.expneurol.2004.06.023 15473978 (Pubitemid 39335704)
23. Enhancement of neuroplasticity through upregulation of beta1-integrin in human umbilical cord-derived stromal cell implanted stroke model. Ding DC, Shyu WC, Chiang MF, Lin SZ, Chang YC, Wang HJ, Su CY, Li H, Neurobiol Dis 2007 27 339 353 10.1016/j.nbd.2007.06.010 17651977 (Pubitemid 47337188)
24. Implantation of human umbilical cord-derived mesenchymal stem cells as a neuroprotective therapy for ischemic stroke in rats. Koh SH, Kim KS, Choi MR, Jung KH, Park KS, Chai YG, Roh W, Hwang SJ, Ko HJ, Huh YM, Kim HT, Kim SH, Brain Res 2008 1229 233 248 18634757
25. Delayed administration of human umbilical tissue-derived cells improved neurological functional recovery in a rodent model of focal ischemia. Zhang L, Li Y, Zhang C, Chopp M, Gosiewska A, Hong K, Stroke J Cereb Circ 2011 42 1437 1444 10.1161/STROKEAHA.110.593129
26. Dormant phase and multinuclear cells: two key phenomena in early culture of murine bone marrow mesenchymal stem cells. Ahmadbeigi N, Soleimani M, Gheisari Y, Vasei M, Amanpour S, Bagherizadeh I, Shariati SAM, Azadmanesh K, Amini S, Shafiee A, Arabkari V, Nardi NB, Stem Cells Dev 2011 20 1337 1347 10.1089/scd.2010.0266 21083430
27. Mesenchymal stem cells induce a weak immune response in the rat striatum after allo or xenotransplantation. Rossignol J, Boyer C, Thinard R, Remy S, Dugast AS, Dubayle D, Dey ND, Boeffard F, Delecrin J, Heymann D, Vanhove B, Anegon I, Naveilhan P, Dunbar GL, Lescaudron L, J Cell Mol Med 2009 13 2547 2558 20141619
28. Assessing the potential clinical utility of transplantations of neural and mesenchymal stem cells for treating neurodegenerative diseases. Lescaudron L, Boyer C, Bonnamain V, Fink KD, Lévêque X, Rossignol J, Nerrière-Daguin V, Malouet AC, Lelan F, Dey ND, Michel-Monigadon D, Lu M, Neveu I, von Hörsten S, Naveilhan P, Dunbar GL, Methods Mol Biol 2012 879 147 164 10.1007/978-1-61779-815-3-10 22610559
29. Genetically engineered mesenchymal stem cells reduce behavioral deficits in the YAC 128 mouse model of Huntington's disease. Dey ND, Bombard MC, Roland BP, Davidson S, Lu M, Rossignol J, Sandstrom MI, Skeel RL, Lescaudron L, Dunbar GL, Behav Brain Res 2010 214 193 200 10.1016/j.bbr.2010.05.023 20493905
30. Autologous adult bone marrow stem cell transplantation in an animal model of huntington's disease: behavioral and morphological outcomes. Lescaudron L, Unni D, Dunbar GL, Int J Neurosci 2003 113 945 956 10.1080/00207450390207759 12881187 (Pubitemid 36975650)
31. Brain-derived neurotrophic factor in patients with Huntington's disease. Zuccato C, Marullo M, Vitali B, Tarditi A, Mariotti C, Valenza M, Lahiri N, Wild EJ, Sassone J, Ciammola A, Bachoud-Lèvi AC, Tabrizi SJ, Di Donato S, Cattaneo E, PLoS One 2011 6 22966 10.1371/journal.pone.0022966 21857974
32. Amnion-derived stem cells: in quest of clinical applications. Miki T, Stem Cell Res Ther 2011 2 25 10.1186/scrt66 21596003
33. The role of induced pluripotent stem cells in regenerative medicine: neurodegenerative diseases. Peng J, Zeng X, Stem Cell Res Ther 2011 2 32 10.1186/scrt73 21861938
34. Survival and differentiation of adenovirus-generated induced pluripotent stem cells transplanted into the rat striatum. Fink KD, Rossignol J, Lu M, Leveque X, Hulse TD, Crane AT, Nerriere-Daguin V, Wyse RD, Starski PA, Schloop MT, Dues DJ, Witte SJ, Song C, Vallier L, Nguyen TH, Naveilhan P, Anegon I, Lescaudron L, Dunbar GL, Cell Transplant in press